Pidaparti, MahatiGeddes, Gabrielle C.Durbin, Matthew D.2024-07-312024-07-312024-04-26Pidaparti M, Geddes GC, Durbin MD. Clinical Genetic and Genomic Testing in Congenital Heart Disease and Cardiomyopathy. J Clin Med. 2024;13(9):2544. Published 2024 Apr 26. doi:10.3390/jcm13092544https://hdl.handle.net/1805/42499Congenital heart disease (CHD) and cardiomyopathies are the leading cause of morbidity and mortality worldwide. These conditions are often caused by genetic factors, and recent research has shown that genetic and genomic testing can provide valuable information for patient care. By identifying genetic causes, healthcare providers can screen for other related health conditions, offer early interventions, estimate prognosis, select appropriate treatments, and assess the risk for family members. Genetic and genomic testing is now the standard of care in patients with CHD and cardiomyopathy. However, rapid advances in technology and greater availability of testing options have led to changes in recommendations for the most appropriate testing method. Several recent studies have investigated the utility of genetic testing in this changing landscape. This review summarizes the literature surrounding the clinical utility of genetic evaluation in patients with CHD and cardiomyopathy.en-USAttribution 4.0 InternationalCongenital heart diseaseCardiomyopathyGenetic testingGenomic testingPersonalized medicineGenome sequencingArticle